Gcina imali ngalezi zikhetho zogqirha
Ngokuqhelekileyo, ingqalelo yokungaphumeleli kwimeko yokuxhatshazwa kwengxaki ifunyanwe kubantwana kwaye le meko ihlala ihlala isakhula kwaye emva koko ikhulile. Abantwana abane-ADHD bawela kwiintlobo ezintathu:
- Eyona nto ingabonakaliyo
- Eyona nto ingalindelekanga
- Intlangano
Nangona abanye abantu abane- ADHD "bephuma" eso sifo, kuqikelelwa ukuba amaninzi angama-80 ekhulwini abantu bathwala le meko ngokudala.
Abantu abadala abane-ADHD baninzi kwaye abanakuxhatshazeka kwaye endaweni engayithobeliyo.
Amachiza amaninzi aphatha i-ADHD. Amachiza aqhelekileyo anqunyelwe ukuphatha i-ADHD ayakhuthaza kwaye aquka ezininzi izibizo zamagama. Nangona kunjalo, ezinye iindlela ezingaphantsi kweendleko ezinokuthi zingabonakali-xa zingasadingeki ngumniki-inshorensi wakho.
Mayeza aqhelekileyo
Amachiza angaphezu kweyeshumi athathe i-ADHD:
- Adderall kunye neAdderall XR (amphetamine kunye ne-dextroamphetamine)
- I-Concerta (i-methylphenidate)
- I-Daytrana (i-methylphenidate)
- Desoxyn (methamphetamine)
- I-Dexedrine (dextroamphetamine)
- I-Focalin ne-Focalin XR (dexmethylphenidate)
- Intuniv (guanfacine)
- I-CD yeMetadate kunye ne-Metadate ER (i-methylphenidate)
- I-Methylin ne-Methylin ER (i-methylphenidate)
- URitalin, uRitalin LA kunye noRitalin SR (i-methylphenidate)
- I-Quillivant XR (i-methylphenidate)
- Strattera (i-atomoxetine)
- Vyvanse (lisdexamfetamine)
Inqaku, i-XR, ER, kunye ne-LR zichanelo zibonisa amalungiselelo okukhululwa okwandisiweyo.
Ngaphezu koko, uRitalin SR yindlela ekhululekile yokukhululwa kaRitalin. Ekugqibeleni, onke la mayeza ngaphandle kwe-Intuniv avuselela. (I-Intuniv yipilisi ye-antiadrenergic eyenza isistim se-sympathetic system (servous system) sokunciphisa uxinzelelo lwegazi. Isetyenziselwa ukuphatha i-hypertension ne-ADHD.)
Kwimiyeza echazwe ngasentla, kuphela i-Intuniv, i-Quillivant XR, i-Strattera, ne-Vyvanse ngamagama e-brand.
Zonke ezinye iimachiza zingathengwa njenge-generics.
Ulwahlulo lweendleko
Amachiza egama leBhanki ayabiza. Amachiza e-Generic ayinxalenye yeendleko ezincinci ezisebenzayo kunye negama lesigama-magama kwaye zihlolisiswe kwaye zivunyiwe yi-FDA, nazo.
Ngokomzekelo, ngoJuni 2015, i-tablet ye-10-mg ye-Focalin ixabisa malunga ne-1.40. I-tablet ye-10-mg ye-dexmethylphenidate, ngakolunye uhlangothi, ibiza i $ 0.63. Ukutshintshelwa kumachiza anjalo kungakugcina amakhulu okanye amawaka eedola kwi-ADHD unyango ngamnye kunyaka.
Ukongezelela, xa kuthelekiswa nemilinganiselo ye-generic, ingadla ixesha eliphindwe ngaphezulu ukuthenga amalungiselelo okukhululwa. Nangona kulungele ukuthabatha ukukhutshwa kwexesha elide ngenxa yokuba kuncinci amanani, unako ukugcina imali eninzi ngokuguqula iindlela ezenziweyo ezimfutshane.
Inkxaso yeNtlawulo
Ukuba unenkathazo yokuhlawula imishanguzo ye-ADHD, khawuleza uxelele ugqirha ugqirha uze ucele malunga nezinye iindlela ezikhoyo. Ugqirha unokukunika okukhethwa kukho kunye nezinye iindlela eziza kunciphisa iindleko zemithi ye-ADHD. Ngokomzekelo, iCVS / Caremark- njengabanye abathengisi abaninzi bee-pharmacy ezinkulu-inikeza i-formulary yexabiso enokumiselwa kwixabiso eliphantsi. Ngaphezu koko, iinkqubo zokuncedisa isigulane nazo ziyafumaneka kwiindawo ezininzi.
Ezi nkqubo zincedisa iindleko zonyango.
Isilumkiso Ngezinto Ezikhuthazayo
Ukusetyenziswa kwezivuselelo zokuphatha abantu abadala abane-ADHD akuqondwa kakuhle. Nangona iingxelo zezinto ezikhuthaza abantu abadala, ukukhathazeka malunga nokusebenza nokukhusela kokusetyenziswa okukhuthazayo kweli qela lamanani umfanekiso. Ngokukodwa, uphando oluthile lubonisa ukuba abantu abadala abane-ADHD abazithabathelayo banomngcipheko okhuselekileyo wokubandezeleka, ukuxhalaba kunye nokunyuka kwixinzelelo legazi.
Imithombo ekhethiweyo
Ropper AH, Samuels MA, Klein JP. Isahluko 28. UkuPhuculo oluqhelekileyo kunye nokuPhelelwa koPhuhliso lweNkqubo yeNervous. Ku: Ropper AH, Samuels MA, Klein JP. eds. I-Adams ne-Victor's Principles of Neurology, i-10e Searight H, i-Shinabarger C. Inkcazo yokungabi nakwi-Disperactivity Disorder. Ku: Feldman MD, Christensen JF,
Satterfield JM. eds. Uncedo lweMpilo: Isikhokelo seZenzo zoKliniki, 4e . New York, NY: McGraw-Hill; 2014. eNew York, NY: McGraw-Hill; 2014.